Literature DB >> 14612292

Clinical significance of TGF- beta1 and beta-glucuronidase synchronous detection in human pancreatic cancer.

Hui Yue1, Bo Yang, Hong Zhang, Shan-De Zhu, Xiao-Ju Du, Xin-Li Feng, Zhong Yu, Yu-Ting Xia, Jie-Ping Yu.   

Abstract

OBJECTIVE: To investigate the relation of transfer growth factor (TGF-beta1) and beta-glucuronidase (beta-GCD) on the occurrence and progress of pancreatic cancer.
METHODS: The expression of TGF-beta1 and beta-GCD in the pancreatic cancer tissue and normal pancreatic tissue was determined synchronously using ABC method of immunohistochemistry.
RESULTS: The percentage of TGF-beta1 positive cells was significantly higher in pancreatic cancer tissue (43.8%+/-5.2%) than in adjacent pancreatic tissue (28.7%+/-3.6%, P<0.01). The worse the cancer cells differentiated and lymph nodes metastasis, the more over-expression of TGF-beta1. The percentage of beta-GCD positive cells was also significantly higher in the pancreatic cancer tissue (62.5%+/-4.1%) than in the adjacent pancreatic tissue (33.5%+/-2.8%, P<0.01). The degree of over-expression of beta-GCD was related to the degree of cancer cells differentiation, but not to the lymph nodes metastasis. The expression of TGF-beta1 was significantly correlated with the expression of beta-GCD in pancreatic cancer tissue.
CONCLUSIONS: The genesis of pancreatic cancer results from multi-factor, multi-step and multi-gene variation. The synchronous detection of TGF-beta1 and beta-GCD helps to determine the malignant degree of tumors and the prognosis of patients with such disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14612292

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  6 in total

1.  Overestimation of flavonoid aglycones as a result of the ex vivo deconjugation of glucuronides by the tissue β-glucuronidase.

Authors:  Qing-Yi Lu; Lifeng Zhang; Guido Eibl; Vay Liang W Go
Journal:  J Pharm Biomed Anal       Date:  2013-10-05       Impact factor: 3.935

2.  Detection of baicalin metabolites baicalein and oroxylin-a in mouse pancreas and pancreatic xenografts.

Authors:  Qing-Yi Lu; Lifeng Zhang; Aune Moro; Monica C Chen; Diane M Harris; Guido Eibl; Vay-Liang W Go
Journal:  Pancreas       Date:  2012-05       Impact factor: 3.327

3.  Quercetin aglycone is bioavailable in murine pancreas and pancreatic xenografts.

Authors:  Lifeng Zhang; Eliane Angst; Jenny L Park; Aune Moro; David W Dawson; Howard A Reber; Guido Eibl; O Joe Hines; Vay-Liang W Go; Qing-Yi Lu
Journal:  J Agric Food Chem       Date:  2010-06-23       Impact factor: 5.279

4.  In silico analysis of combinatorial microRNA activity reveals target genes and pathways associated with breast cancer metastasis.

Authors:  Alan A Dombkowski; Zakia Sultana; Douglas B Craig; Hasan Jamil
Journal:  Cancer Inform       Date:  2011-02-17

Review 5.  Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review.

Authors:  Yandiswa Yolanda Yako; Deirdré Kruger; Martin Smith; Martin Brand
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

Review 6.  Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers.

Authors:  Geou-Yarh Liou
Journal:  J Immunol Res       Date:  2017-12-12       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.